Pharmaceutical

FDA accepts Mesoblast’s latest BLA for paediatric GvHD ...

The latest resubmission addressed remaining CMC concerns, with the FDA confirmin...

HHS gives thumbs down to bluebird’s fertility support p...

The US government will not give bluebird bio the opportunity to offer fertility ...

J&J drops Addex’s epilepsy treatment after flunking in ...

A Phase II trial with Johnson and Johnson (J&J) and Addex’s epilepsy drug had fa...

Oscotec sees highest patent filings and grants during J...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Dechra Pharmaceuticals sees highest patent filings and ...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Oramed Pharmaceuticals sees highest patent filings and ...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Orion sees highest patent filings and grants during May...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Kiniksa Pharmaceuticals sees highest patent filings and...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Y-mAbs Therapeutics sees highest patent filings and gra...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Medicover sees highest patent filings and grants during...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

iTeos Therapeutics sees highest patent filings and gran...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Rusan Pharma’s API Plant in Ankleshwar Receives USFDA G...

Rusan Pharma's new facility in India will enhance its global capabilities and ex...

Certara sees highest patent filings and grants during J...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

FDA launches new rare disease innovation hub

The new hub will act as a central point of connection and engagement for the rar...

BMS gains EMA validation for Opdivo/Yervoy combo in liv...

The Opdivo/Yervoy combination demonstrated statistically and clinically signific...

Tech leader’s $125m boosts Parker Institutes immunother...

The Parker Institute for Cancer Immunotherapy was founded in 2016 by tech entrep...